FREVECITINIB
UNII 5N5L287M8T

Substance Identification & Data

This profile provides standardized clinical and technical data for Frevecitinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5N5L287M8T.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1299417-07-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5N5L287M8T

CAS Registry Number

1299417-07-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

FREVECITINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C22H21N7O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ASOKEXGIQLZRHH-HNNXBMFYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C206915

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

67123870

Unique identification number in the NCBI database of chemical substances.

INN ID

13027

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-167

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c2n(C)c(n([C@H]3CCCN(C(CC#N)=O)C3)c2nc(-c4cnn5c4cccc5)c1)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Frevecitinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.